You are here: All Products  > ImmuneOnco Stages $30 Million Hong Kong IPO for Innate/Adaptive Immunity Drugs

ImmuneOnco Stages $30 Million Hong Kong IPO for Innate/Adaptive Immunity Drugs

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products